3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
31
Neoplasm Metastasis
6
Ovarian Neoplasms
5
Endometrial Neoplasms
5
Triple Negative Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Prostatic Neoplasms
3
Neoplasms
3
Advanced Breast Cancer
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms by Site
2
Melanoma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Diseases
2
Uterine Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Genital Neoplasms, Female
1
Genetic Diseases, Inborn
1
Fallopian Tube Neoplasms
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Esophageal Squamous Cell Carcinoma
1
Colonic Neoplasms
1
Interventions
Specimen Handling
2
olaparib
1
durvalumab
1
cediranib
1
capivasertib
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Fluid Therapy
1
Disulfides
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Endometrioid
×
Fulvestrant
×
30 days
×
Clear all
No trials found.